Financials
Financial year 2025
Revenue
€ 27.1 million
▲ 86% vs 2024
Profit
Growing€ 1.6 million
▲ 132% vs 2024
Debts
Low€ 8.1 million
▲ 197% vs 2024
AXONE PHARMA from Braine-l'Alleud, company number BE0830551216, closed financial year 2025 with a result of € 1.6 million after tax. For that financial year AXONE PHARMA recorded revenue of € 27.1 million and equity of € 8.1 million. Compared with financial year 2024, the result moved from € 695,941 to € 1.6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.
What happened at AXONE PHARMA?
What happened at AXONE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1.6 million (▲ 132% vs 2024). Source: NBB ↗
- New establishment in Braine-l'Alleud. KBO
- New establishment in Braine-l'Alleud. KBO
- Start of the company according to the CBE. KBO
In short
From € 2.5 million profit in 2021 to € 1.6 million profit in 2025.
Paid € 2.4 million in corporate taxes since 2021.
Best year ever: 2021, with € 2.5 million profit.
Paid out € 3.5 million in dividends to the owners in total.
A new publication or filing at AXONE PHARMA? We notify you, reason included.
Follow AXONE PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind AXONE PHARMA are Suru Consult and Alexo. The same people are also behind SDC, HC Pharma, SODIAP, APOTHEEK JENNE and PANNOC CHEMIE.
Directors
According to the 2025 annual accounts
Managing director · represented by Ruben Suply
Establishments
Establishment units
Physical locations of this company
Boulevard de France 9 box A
1420 Braine-l'Alleud
Avenue de Finlande 8
1420 Braine-l'Alleud
Active since 1 January 2025
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 53 companies are registered at this address.
MERIDIAN BIOSCIENCE EUROPE
€ 406,506 gross margin · 2025
ODYSSEY FINANCIAL TECHNOLOGIES
€ 963,129 gross margin · 2025
SET SEVEN
€ -41,144 gross margin · 2025
TAXI BERNARD DUBOIS
€ 3,463 gross margin · 2025
Elite Limousine Service
€ 88,566 gross margin · 2024
+48 more
Details
- Company number
- 0830.551.216
- VAT number
- BE 0830.551.216
- Registered office
- Boulevard de France 9 bus A, 1420 Braine-l'Alleud
- Names & denominations
- AXONE PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 October 2010
- Peppol
- Active · Active since 17 Sept 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Handelsbemiddeling in de groothandel in andere specifieke goederen